In the fall, rogue FDA researcher David Graham pointed to Crestor as a drug with potential safety problems.

FORBES

Some hope that potential safety problems with currently marketed stents won't be a problem with the Conor CoStar.

FORBES: J&J Targets Stent Maker

The FDA defends its own use of the data for safety surveillance and it issues frequent MedWatch alerts on potential problems.

WSJ: Searching for Side Effects